Literature DB >> 2834950

Role of bradykinin in hypertension and the antihypertensive effect of angiotensin-converting enzyme inhibitors.

I Gavras1, H Gavras.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2834950     DOI: 10.1097/00000441-198804000-00015

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  3 in total

Review 1.  Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

2.  Local L-NG-monomethyl-arginine attenuates the vasodilator action of bradykinin in the human forearm.

Authors:  K P O'Kane; D J Webb; J G Collier; P J Vallance
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

3.  Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort study.

Authors:  Jason Roy; Nirav R Shah; G Craig Wood; Raymond Townsend; Sean Hennessy
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-04-09       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.